As in the LEAN study, the primary outcome is histologic resolution of NASH without worsening of fibrosis after 72 weeks of treatment, while secondary outcomes include improvement in liver fibrosis (1 stage) with no worsening of NASH, NAFLD activity score, as well as multiple serum markers of fibrosis
10.1053/j.seminhematol.2018.04.014 Semin
Using Dandelion Healths GLP-1 Data Library, we conducted a study to compare outcomes for patients who have taken a GLP-1 and a matched cohort of patients who have never taken a GLP-1, but were very similar clinically, to evaluate whether GLP-1 use in the real world is as effective as results reported in clinical trials
Average lipid droplet volume was determined by dividing total volume by total object count
Chemosensitization of aflatoxigenic fungi to antimycin A and strobilurin using salicylaldehyde, a volatile natural compound targeting cellular antioxidation system
FAQ What is peptide therapy used for